These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 20140311

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex.
    Wade RL, Chaudhari P, Natoli JL, Taylor RJ, Nathanson BH, Horn DL.
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):361-7. PubMed ID: 23774005
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K, Itraconazole Neutropenia Study Group.
    Ann Intern Med; 2001 Sep 18; 135(6):412-22. PubMed ID: 11560454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of Intralipid infusion in reducing amphotericin-B-associated nephrotoxicity in head and neck invasive fungal infection: A randomized, controlled trial.
    Hasibi M, Jafari S, Manshadi SA, Asadollahi M, Salehi M, Zarch VV, Kouhi A.
    Ear Nose Throat J; 2017 Feb 18; 96(2):E18-E22. PubMed ID: 28231371
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Continuous infusion of escalated doses of amphotericin B deoxycholate: an open-label observational study.
    Imhof A, Walter RB, Schaffner A.
    Clin Infect Dis; 2003 Apr 15; 36(8):943-51. PubMed ID: 12684904
    [Abstract] [Full Text] [Related]

  • 15. Minimizing nephrotoxicity using continuous infusion of deoxycholate amphotericin B.
    Gwee A, Cranswick N, Connell TG, Curtis N.
    Pediatr Infect Dis J; 2014 Oct 15; 33(10):1098. PubMed ID: 25361191
    [No Abstract] [Full Text] [Related]

  • 16. Continuous infusion of amphotericin B: preliminary experience at Faculdade de Medicina da Fundação ABC.
    Uehara RP, Sá VH, Koshimura ET, Prudente FV, Tucunduva LT, Gonçalves MS, Samano ES, del Giglio A.
    Sao Paulo Med J; 2005 Sep 01; 123(5):219-22. PubMed ID: 16358096
    [Abstract] [Full Text] [Related]

  • 17. Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
    Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW.
    N Engl J Med; 2010 Feb 11; 362(6):504-12. PubMed ID: 20147716
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Amphotericin B infusion-related toxicity: comparison of two- and four-hour infusions.
    Nicholl TA, Nimmo CR, Shepherd JD, Phillips P, Jewesson PJ.
    Ann Pharmacother; 1995 Nov 11; 29(11):1081-7. PubMed ID: 8573948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.